Rasuvo and Rashes - a phase IV clinical study of FDA data

Summary:

Rashes is reported as a side effect among people who take Rasuvo (methotrexate), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Enbrel, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Rashes when taking Rasuvo. It is created by eHealthMe based on reports of 3,515 people who have side effects when taking Rasuvo from the FDA, and is updated regularly.

What is Rasuvo?

Rasuvo has active ingredients of methotrexate. It is often used in psoriatic arthritis. eHealthMe is studying from 3,702 Rasuvo users. Check the latest studies of Rasuvo.

What is Rashes?

Rashes (redness) is found to be associated with 3,712 drugs and 6,212 conditions by eHealthMe. Check the latest studies of Rashes.

On Jul, 12, 2026

3,515 people reported to have side effects when taking Rasuvo.
Among them, 100 people (2.84%) have Rashes.

Among these 100 people:

How long have people been on Rasuvo when they have Rashes? *

What is the gender of people who have Rashes when taking Rasuvo? *

female: 92.78 %
male: 7.22 %

What is the age of people who have Rashes when taking Rasuvo? *

What are other drugs people take besides Rasuvo? *

What are other side effects people have besides Rashes? *

Drug Ineffective: 14 people, 14.00%
Nausea (feeling of having an urge to vomit): 12 people, 12.00%
Joint Pain: 11 people, 11.00%
Pain: 11 people, 11.00%
Sinusitis (inflammation of sinus): 9 people, 9.00%
Headache (pain in head): 8 people, 8.00%
Peripheral Swelling: 8 people, 8.00%
Joint Swelling: 7 people, 7.00%
Nausea And Vomiting: 7 people, 7.00%
Pain In Extremity: 7 people, 7.00%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 59 people, 59.00%
Immunodeficiency Common Variable: 7 people, 7.00%
Stress And Anxiety: 5 people, 5.00%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 5 people, 5.00%
Pain: 4 people, 4.00%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 4 people, 4.00%
Osteopenia (a condition where bone mineral density is lower than normal): 3 people, 3.00%
Fibromyalgia (a long-term condition which causes pain all over the body): 3 people, 3.00%
Immune System Disorder: 3 people, 3.00%
Impaired Healing: 3 people, 3.00%

* Approximation only. Some reports may have incomplete information.

Do you take Rasuvo and have Rashes?

- Check whether Rashes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rasuvo:

Rasuvo (3,702 reports)

Rashes treatments and more:

Rashes (702,909 reports)

Browse all side effects of Rasuvo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rashes:

Rashes (3,712 drugs)

Browse all the conditions that are associated with Rashes:

Rashes (6,212 conditions)

Related publications that referenced our studies

Mathai, P. C., Andrade, N. N., Aggarwal, N., Nerurkar, S., & Kapoor, P. , "Low-dose methotrexate in rheumatoid arthritis: a potential risk factor for bisphosphonate-induced osteonecrosis of the jaw", Oral and maxillofacial surgery, 2018 Jan .
Mathai, P. C., Andrade, N. N., Aggarwal, N., Nerurkar, S., & Kapoor, P. , "Low-dose methotrexate in rheumatoid arthritis: a potential risk factor for bisphosphonate-induced osteonecrosis of the jaw", Oral and maxillofacial surgery, 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on methotrexate (the active ingredients of Rasuvo) and Rasuvo (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.